BioCorRx Now Available in Tampa

Revolutionary Addiction Treatment Comes to Tampa, FL

For those who suffer from addiction in the Tampa area and seek measures to combat their condition, they can now take advantage of our novel weapon to aid them in their struggle. The BioCorRx
Recovery Program, offered through Genesis Alcohol & Addiction alternatives Inc., is now available in this Florida west coast city. Our program for conquering the ills of opioid drug and alcohol addiction is one of a kind. It's the only course of naltrexone treatment administered through a subcutaneous, sustained-release implant.

BioCorRx Recovery Program in Depth

The BioCorRx Recovery Program is an outpatient medication-assisted treatment plan for alcohol and opioid drug addiction. Our unique protocol exchanges the historical approach for treating addiction with one that is innovatively geared toward a more successful outcome. It consists of two parts, the implant and professional counseling. Our program doesn't surgically insert an implant into your body, wish you luck and hope you'll make it on your own. We'll never make you feel as though you're one of a herd traipsing through. 

Our system is built upon individualized attention for each person we treat. From day one of your enrollment, an experienced certified addiction professional will be assigned to you for the duration of your treatment. That practitioner will coordinate all of your pre-op scheduling which includes a physical exam, appropriate blood tests, an EKG and, lastly, the implant surgery. Additionally, as a licensed mental health counselor, she or he will arrange for peer support and set up your individual counseling sessions. 

What the Implant Does and How 

Naltrexone is the generic equivalent of the federally-sanctioned opioid receptor antagonist, naloxone. In general, the implant remains functional and situated for six months. It is compounded specifically for each client after an authorized medical provider's evaluation and determination that the person is suitable for the implant's procedure and philosophy. Accordingly, an applicable prescription is then written and issued. Pharmacies entrusted with preparing each implant are subject to all appropriate state and federal compounding laws. Used in conjunction with the attendant features of our program, the implant is formulated to circumvent the paths to dependency. 

It accomplishes this by blocking those receptors in the midbrain that cause the release of the neurotransmitter, dopamine. Elevated levels of dopamine being sent to other nerves heighten the feelings of enjoyment, pleasure and gratification. When artificial stimulants -- opiates or alcohol -- are introduced, we can easily become ensnared in a trap of unhealthy behavior. If it feels good, we continue doing it. Before we know it, full-fledged addiction is propelling our conduct. 

One noteworthy factor of naloxone is that it's devoid of the deleterious addictive side effects common to other addiction-fighting drugs such as methadone and suboxone. Therefore, possessing no inherent potential for an unwanted added dependency, the beneficial properties of naltrexone are automatically boosted. The biodegradable implant contains two extended-release pellets of the drug. This potent medication is formulated to eliminate or drastically reduce the notorious cravings which can thwart recovery. Moreover, should a client give in and use or imbibe anyway, the implant will quash that seductive sensation of floating on cloud nine. No pleasurable feelings can significantly sneak through as the medication continuously checks those midbrain receptors. 

Counseling begins after the naltrexone implantation. This vital element consists of 16-20 sessions which focus on 35 strategies to help you remain unshackled by the chains of addiction. There is no time limit for the guidance sessions though most clients complete them between 90 and 120 days. The peer support component of our program is simultaneously activated with the sessions.

Some Caveats

Naltrexone is a MAT that has been authorized by the FDA for alcohol and opiate dependency since the mid 1990s. While the federal agency hasn't given its final approval of the implantation method, that doesn't question the efficacy of the medication for its intended purpose.
Some patients have reported adverse reactions around the implantation site, including inflammation and minor skin irritations. In most cases, the symptoms abated over a relatively short period. In the event of a severe indication, a physician's counsel is advised. Dependent upon medical advice, it may be prudent to remove the implant.
Individuals with renal or hepatic disease should not seek implant treatment. There is evidentiary documentation that contraindications may exist for such patients. 
Expectant or nursing mothers should not seek naloxone treatment before consulting with their physicians.
An obvious small lump may remain at the surgical site upon healing.